|
Journal of Histochemistry and Cytochemistry, Vol. 45, 957-964, Copyright © 1997 by The Histochemical Society, Inc.
Differential Expression of CD66a (BGP), a Cell Adhesion Molecule of the Carcinoembryonic Antigen Family, in Benign, Premalignant, and Malignant Lesions of the Human Mammary Gland
Lutz Riethdorfa,
Björn W. Lisboaa,
Ute Henkela,
Markus Naumanna,
Christoph Wagenerb, and
Thomas Löninga
a Abteilung für Gynäkologische Histopathologie, Frauenklinik, Universitätskrankenhaus Eppendorf, Hamburg, Germany
b Abteilung für Klinische Chemie, Medizinische Klinik, Universitätskrankenhaus Eppendorf, Hamburg, Germany
Correspondence to:
Thomas Löning, Abteilung für Gynäkologische Histopathologie, Frauenklinik, Universitätskrankenhaus Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.
CD66a, also known as biliary glycoprotein (BGP), is a member of the carcinoembryonic antigen (CEA) family and the human homologue of the rat cell-CAM. There is evidence that aberrant expression or loss of CD66a in tumor tissue is of biological significance. No data about its expression in breast carcinoma cells and only sparse information about the expression of CD66a in normal breast are available thus far. In this study we used monoclonal antibodies to analyze the expression of CD66a and CEA in normal tissue, benign lesions, and in noninvasive and invasive carcinomas of the mammary gland. In normal tissue and benign lesions, CD66a was consistently expressed at the apical sites of epithelial cells and in myoepithelia, whereas CEA was absent or was restricted only to some apical membranes within the ductal tree. The specific staining of myoepithelia was most evident in pseudoinfiltrative radial scars and sclerosing adenosis. However, the apical expression of CD66a disappeared with the development of the malignant phenotype in noninvasive and invasive carcinomas, and changed gradually from low- to high-grade noninvasive carcinomas into a predominant uniform membrane staining all around the atypical cells. CEA expression was irregular in intensity and distribution. The native apical CD66a staining was partially preserved in some highly differentiated invasive carcinomas with a better prognosis, such as tubular and papillary carcinomas. These findings indicate that loss of CD66a expression rather than a change in staining patterns coincides with the development of the malignant phenotype. (J Histochem Cytochem 45:957-963, 1997)
Key Words:
CD66a, biliary glycoprotein, CEA, cell adhesion, CAM, immunohistochemistry, mammary gland

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Xi, A. Feber, V. Gupta, M. Wu, A. D. Bergemann, R. J. Landreneau, V. R. Litle, A. Pennathur, J. D. Luketich, and T. E. Godfrey
Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer
Nucleic Acids Res.,
November 1, 2008;
36(20):
6535 - 6547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Yu, E. M. C. Chow, H. Wong, J. Gu, O. Mandelboim, S. D. Gray-Owen, and M. A. Ostrowski
CEACAM1 (CD66a) Promotes Human Monocyte Survival via a Phosphatidylinositol 3-Kinase- and AKT-dependent Pathway
J. Biol. Chem.,
December 22, 2006;
281(51):
39179 - 39193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-M. Bamberger, J. Briese, J. Gotze, I. Erdmann, H. M. Schulte, C. Wagener, and P. Nollau
Stimulation of CEACAM1 expression by 12-O-tetradecanoylphorbol-13-acetate (TPA) and calcium ionophore A23187 in endometrial carcinoma cells
Carcinogenesis,
March 1, 2006;
27(3):
483 - 490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-M. Bamberger, V. Minas, S. N. Kalantaridou, J. Radde, H. Sadeghian, T. Loning, I. Charalampopoulos, J. Brummer, C. Wagener, C. M. Bamberger, et al.
Corticotropin-Releasing Hormone Modulates Human Trophoblast Invasion through Carcinoembryonic Antigen-Related Cell Adhesion Molecule-1 Regulation
Am. J. Pathol.,
January 1, 2006;
168(1):
141 - 150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Laurie, M. M. Comegys, M. P. Carreiro, J. F. Brown, D. L. Flanagan, K. E. Brilliant, and D. C. Hixson
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1a-4L Suppression of Rat Hepatocellular Carcinomas
Cancer Res.,
December 1, 2005;
65(23):
11010 - 11017.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Briese, M. Oberndorfer, C. Patschenik, H. M. Schulte, A. Makrigiannakis, T. Loning, and A.-M. Bamberger
Osteopontin Is Colocalized with the Adhesion Molecule CEACAM1 in the Extravillous Trophoblast of the Human Placenta and Enhances Invasion of CEACAM1-Expressing Placental Cells
J. Clin. Endocrinol. Metab.,
September 1, 2005;
90(9):
5407 - 5413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Phan, C.-J. Cheng, M. Galfione, F. Vakar-Lopez, J. Tunstead, N. E. Thompson, R. R. Burgess, S. M. Najjar, L.-Y. Yu-Lee, and S.-H. Lin
Identification of Sp2 as a Transcriptional Repressor of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Tumorigenesis
Cancer Res.,
May 1, 2004;
64(9):
3072 - 3078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hoshiya, V. Gupta, H. Kawakubo, E. Brachtel, J. L. Carey, L. Sasur, A. Scott, P. K. Donahoe, and S. Maheswaran
Mullerian Inhibiting Substance Promotes Interferon {gamma}-induced Gene Expression and Apoptosis in Breast Cancer Cells
J. Biol. Chem.,
December 19, 2003;
278(51):
51703 - 51712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kirshner, D. Schumann, and J. E. Shively
CEACAM1, a Cell-Cell Adhesion Molecule, Directly Associates with Annexin II in a Three-dimensional Model of Mammary Morphogenesis
J. Biol. Chem.,
December 12, 2003;
278(50):
50338 - 50345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Jantscheff, L. Terracciano, A. Lowy, K. Glatz-Krieger, F. Grunert, B. Micheel, J. Brummer, U. Laffer, U. Metzger, R. Herrmann, et al.
Expression of CEACAM6 in Resectable Colorectal Cancer: A Factor of Independent Prognostic Significance
J. Clin. Oncol.,
October 1, 2003;
21(19):
3638 - 3646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Sienel, S. Dango, U. Woelfle, A. Morresi-Hauf, C. Wagener, J. Brummer, W. Mutschler, B. Passlick, and K. Pantel
Elevated Expression of Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 Promotes Progression of Non-Small Cell Lung Cancer
Clin. Cancer Res.,
June 1, 2003;
9(6):
2260 - 2266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kirshner, C.-J. Chen, P. Liu, J. Huang, and J. E. Shively
CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture
PNAS,
January 21, 2003;
100(2):
521 - 526.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Plunkett and P. A. Ellis
CEACAM1: A Marker With a Difference or More of the Same?
J. Clin. Oncol.,
November 1, 2002;
20(21):
4273 - 4275.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Laack, H. Nikbakht, A. Peters, C. Kugler, Y. Jasiewicz, L. Edler, J. Brummer, U. Schumacher, and D. K. Hossfeld
Expression of CEACAM1 in Adenocarcinoma of the Lung: A Factor of Independent Prognostic Significance
J. Clin. Oncol.,
November 1, 2002;
20(21):
4279 - 4284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Volpert, W. Luo, T.-J. Liu, V. T. Estrera, C. Logothetis, and S.-H. Lin
Inhibition of Prostate Tumor Angiogenesis by the Tumor Suppressor CEACAM1
J. Biol. Chem.,
September 13, 2002;
277(38):
35696 - 35702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Thies, I. Moll, J. Berger, C. Wagener, J. Brummer, H.-J. Schulze, G. Brunner, and U. Schumacher
CEACAM1 Expression in Cutaneous Malignant Melanoma Predicts the Development of Metastatic Disease
J. Clin. Oncol.,
May 15, 2002;
20(10):
2530 - 2536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Brummer, A. Ebrahimnejad, R. Flayeh, U. Schumacher, T. Loning, A.-M. Bamberger, and C. Wagener
cis Interaction of the Cell Adhesion Molecule CEACAM1 with Integrin {beta}3
Am. J. Pathol.,
August 1, 2001;
159(2):
537 - 546.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. M. Skubitz, K. D. Campbell, and A. P. N. Skubitz
Synthetic Peptides of CD66a Stimulate Neutrophil Adhesion to Endothelial Cells
J. Immunol.,
April 15, 2000;
164(8):
4257 - 4264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-M. Bamberger, S. Sudahl, T. Loning, C. Wagener, C. M. Bamberger, P. Drakakis, C. Coutifaris, and A. Makrigiannakis
The Adhesion Molecule CEACAM1 (CD66a, C-CAM, BGP) Is Specifically Expressed by the Extravillous Intermediate Trophoblast
Am. J. Pathol.,
April 1, 2000;
156(4):
1165 - 1170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sadekova, N. Lamarche-Vane, X. Li, and N. Beauchemin
The CEACAM1-L Glycoprotein Associates with the Actin Cytoskeleton and Localizes to Cell-Cell Contact through Activation of Rho-like GTPases
Mol. Biol. Cell,
January 1, 2000;
11(1):
65 - 77.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J Huang, J. Hardy, Y Sun, and J. Shively
Essential role of biliary glycoprotein (CD66a) in morphogenesis of the human mammary epithelial cell line MCF10F
J. Cell Sci.,
January 12, 1999;
112(23):
4193 - 4205.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
V. T. Estrera, D.-T. Chen, W. Luo, D. C. Hixson, and S.-H. Lin
Signal Transduction by the CEACAM1 Tumor Suppressor. PHOSPHORYLATION OF SERINE 503 IS REQUIRED FOR GROWTH-INHIBITORY ACTIVITY
J. Biol. Chem.,
April 27, 2001;
276(18):
15547 - 15553.
[Abstract]
[Full Text]
[PDF]
|
 |
|
The Journal of Histochemistry & Cytochemistry
is owned, published, and licensed by
The Histochemical Society © 1997
|
|
|